European Neuromuscular Centre Themed Workshops
The NMD4C is excited to share that the European Neuromuscular Centre (ENMC) has announced a new initiative: Themed Workshops!
For more than 28 years, the ENMC has organised 260+ workshops, with topics originating from an international group of experts in the field of neuromuscular diseases (NMD). This is a unique concept where the scientific content of the workshop is submitted by NMD researchers and clinicians and where the logistical organisation and funding of the workshop is facilitated by the ENMC. The ENMC’s workshops are aimed to bring together researchers, clinicians and patient representatives from all over the world to encourage communication and international collaboration on specific neuromuscular conditions. The next deadline for these regular ENMC workshops is 1 September 2021!
For the new Themed Workshops, the ENMC will identify special themes which are prioritised by the needs of the neuromuscular patient and research community. These topics are transversal (relevant across many NMDs), multidisciplinary, unique and sustainable (with a long-lasting impact on the neuromuscular community). Organisers, who would like to pick up the theme and apply for an ENMC workshop are free to further define the rationale, background, objectives and resulting deliverables of the workshop.
The theme for 2021 is Post-Covid-19: Issues and opportunities for the neuromuscular field. This theme was selected to provide learning opportunities from the Covid-19 pandemic in two ways:
1) to evaluate how NMD patients were assessed and their care managed during the self-isolation period, and see chances for continuing part of the online monitoring,
2) to understand how neuromuscular signs and symptoms have developed in non-NMD patients who were infected by the Coronavirus.
The call for organisers who would like to apply for an ENMC workshop on this theme is now open and will run until September 30, 2021. For more information, please visit the ENMC website!
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.